Many bacterial organisms modulate their response to environmental and metabolic cues with riboswitches. The discovery of these short cis-acting RNA elements has drastically changed our understanding of gene regulatory mechanisms in prokaryotes. Riboswitches are especially prevalent in Gram-positive bacteria, exemplified by Bacillus subtilis as a model organism, but are also found to control essential genes in important pathogens such as Bacillus anthracis, Staphylococcus, Enterococcus, Streptococcus, Listeria, Clostridium, and Mycobacterium. Due to their abundance in bacterial pathogens and their essential and specific nature, riboswitches are prime targets for drug and biotechnological development. Arguably the first riboswitch family identified, the T box riboswitch is unique from other characterized riboswitch families in that its effector is not a small molecule, but an essential macromolecule, tRNA. It is also a rare riboswitch system where ligand (tRNA) binding turns on essential gene expression rather than off. This makes the T box riboswitch an especially attractive antibiotic target because small molecules disrupting T box-tRNA interaction would trap the regulated gene in the off state, and the pathogens cannot easily acquire antibiotic resistance through loss-of-function riboswitch mutations. Mechanistically, the T box riboswitch is capable of two interesting functions: 1) recruiting a cognate tRNA from the intracellular tRNA pool through a process somewhat resembles the decoding process inside the ribosome, and 2) sensing the aminoacylation status of the bound tRNA to regulate genes involved in amino acid metabolism and tRNA aminoacylation. Standing in sharp contrast to the fast evolving field of metabolite-sensing riboswitches, mechanistic description of T boxes remain as low-resolution schematics in reviews, until last year when efforts from our group and others pushed the understanding of selective tRNA recognition to near atomic resolution. The combination of research tools including crystal structure determination, small angle X-ray scatting measurement, mutagenesis, chemical probing, and UV crosslinking analyses form the basis for the proposed investigations in this proposal.
We aim to 1) provide a thorough understanding of the tRNA recruitment process by T box Stem I; 2) provide a holistic understanding of tRNA aminoacylation sensing by the Antiterminator domain of T box; and 3) understand the structure-function of an atypical class of T box riboswitch found in Mycobacterium tuberculosis, whose tRNA recognition mechanism cannot be explained by our current mechanistic model.

Public Health Relevance

T box riboswitches control essential genes in many bacterial pathogens. Several characteristics suggest that T box riboswitches are prime targets for antibiotics development. The described structure-function studies of T box riboswitches will provide key mechanistic insights that will enable practical applications to rationally design specific riboswitch inhibitors that may contain antibiotic activities.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM116632-02S1
Application #
9273770
Study Section
Program Officer
Preusch, Peter
Project Start
2015-05-04
Project End
2017-02-28
Budget Start
2016-03-01
Budget End
2017-02-28
Support Year
2
Fiscal Year
2016
Total Cost
$216,700
Indirect Cost
Name
Cornell University
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
872612445
City
Ithaca
State
NY
Country
United States
Zip Code
14850
Xiao, Yibei; Luo, Min; Hayes, Robert P et al. (2017) Structure Basis for Directional R-loop Formation and Substrate Handover Mechanisms in Type I CRISPR-Cas System. Cell 170:48-60.e11
Xiao, Yibei; Ng, Sherwin; Nam, Ki Hyun et al. (2017) How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration. Nature 550:137-141
Battaglia, Robert A; Price, Ian R; Ke, Ailong (2017) Structural basis for guanidine sensing by the ykkC family of riboswitches. RNA 23:578-585